유럽 ​​혈액투석 및 복막투석 시장 – 2031년까지의 산업 동향 및 예측

유럽 ​​혈액투석 및 복막투석 시장 분석 및 규모

혈액투석 및 복막투석 시장은 최신 방법과 기술을 활용하여 상당한 발전을 이루었습니다. 휴대용 투석기 및 원격 모니터링 시스템과 같은 혁신은 환자의 편의성과 치료 결과를 향상시켰습니다. 이러한 성장은 신장 질환의 유병률 증가와 인구 고령화로 인해 촉진되어 효율적이고 접근 가능한 신장 대체 요법에 대한 수요가 증가하고 있습니다.                                

유럽 ​​혈액투석 및 복막투석 시장 규모는 2023년에 267억 7천만 달러로 평가되었으며, 2031년까지 443억 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 6.5%입니다. 이는 시장 가치를 나타냅니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화

시장 정의

혈액투석은 인공 신장 역할을 하는 기계를 통해 체외에서 혈액을 걸러내어 노폐물과 과도한 체액을 제거하는 것을 말합니다. 복막투석은 복부의 내벽(복막)을 자연 필터로 사용합니다. 투석액을 복부로 주입하면 노폐물과 과도한 체액이 혈액에서 체액으로 이동한 다음 배출됩니다. 두 방법 모두 신부전을 치료합니다.           

유럽 ​​혈액투석 및 복막투석 시장 동향

운전자

• 말기 신장 질환(ESRD) 유병률 증가

The escalating prevalence of chronic kidney diseases, such as diabetes and hypertension, fuels the demand for dialysis treatment, propelling market growth. For instance, according to the National Kidney Foundation, approximately 37 million Americans have chronic kidney disease (CKD), with diabetes and high blood pressure being the leading causes. This growing patient pool underscores the imperative for dialysis services, driving innovation and investment in the hemodialysis and peritoneal dialysis market.

• Growing Awareness and Education

Increased awareness campaigns regarding kidney diseases and available treatment options drive early diagnosis and intervention, consequently expanding the patient base for dialysis therapies. For instance, initiatives such as World Kidney Day raise awareness about kidney health globally, encouraging individuals to undergo regular screenings. Early detection enables timely intervention and initiation of dialysis treatment, ultimately fostering market growth by addressing the needs of a larger patient population.

Opportunities

• Rising Preference for Home-Based Dialysis

The preference for home-based dialysis, notably peritoneal dialysis, is surging due to its convenience, cost-effectiveness, and potential to enhance patient outcomes. For instance, in the U.S., the prevalence of home dialysis increased from 15.5% in 2005 to 21.2% in 2016, showcasing a significant shift towards home-based care. This trend reflects a growing recognition among patients and healthcare providers of the benefits associated with home dialysis modalities, propelling market growth in this segment.

• Rising Clinical Advantages of Peritoneal Dialysis

Peritoneal dialysis is gaining traction due to its clinical advantages, including preserving residual kidney function, minimizing dietary restrictions, and offering flexible treatment schedules. For instance, a study published in the Journal of the American Society of Nephrology found that peritoneal dialysis patients retained better residual kidney function compared to those on hemodialysis. Such benefits are driving the increasing adoption of peritoneal dialysis, consequently boosting market demand.

Restraints/Challenges

• High Treatment Costs

The high treatment costs associated with hemodialysis and peritoneal dialysis pose a significant barrier to access, particularly for patients lacking sufficient insurance coverage. This financial burden limits the market's growth potential, as many individuals are unable to afford these therapies, resulting in reduced demand and utilization of dialysis services. 

• Limited Availability in Rural Areas

Limited availability of dialysis facilities in rural areas exacerbates healthcare disparities, particularly affecting patients' access to specialized hemodialysis centers. This constraint hampers market growth by restricting treatment options for individuals with end-stage renal disease in remote regions, leading to unequal access to care and potentially poorer health outcomes for those residing in rural areas. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In June 2023, AWAK Technologies and Singapore General Hospital unveiled a pre-pivotal clinical trial assessing the reliability and effectiveness of the upgraded Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device, signaling a significant advancement in renal care technology
• In January 2023, the FDA granted regulatory authorization to liberDi Ltd., an Israeli device firm, for its innovative continuous ambulatory peritoneal dialysis system, empowering patients to conveniently perform dialysis at home or work, promising greater autonomy and flexibility in managing their treatment
• In March 2022, Nipro Medical Corporation announced the commercial launch of the SURDIAL DX Hemodialysis System in the United States, introducing state-of-the-art equipment designed to optimize dialysis therapy for both patients and healthcare providers, marking a significant milestone in renal healthcare technology advancement

Europe Hemodialysis and Peritoneal Dialysis Market Scope

The market is segmented on the basis of hemodialysis products, dialyzers material type, flux type, hemodialysis modality, hemodialysis water treatment systems, peritoneal dialysis products and services, peritoneal dialysis modality, disease indication, usage and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Hemodialysis Products

• Hemodialysis Machines
• Center-Use Hemodialysis Machines
• Home-Use Hemodialysis Machines
• Hemodialysis Consumables and Supplies

Dialyzers Material Type

• Synthetic Dialyzers
• Cellulose-Based Dialyzers

Flux Type

• High-Flux
• Dialyzers
• Low Flux Dialyzers
• Bloodlines Sets and Tubes
• Hemodialaysis Concentrates/Dialysates
• Alkaline Concentrates
• Acidic Concentrates
• Hemodialysis Access Products
• AV Fistula Needles
• Arteriovenous Grafts
• Central Venous Catheters
• Other Hemodialysis Consumables

Hemodialysis Modality

• Conventional Hemodialysis
• Short Daily Hemodialysis
• Nocturnal Hemodialysis (NHD)

Hemodialysis Water Treatment Systems

• Central Water Disinfection Systems
• Portable Water Disinfection Systems

Peritoneal Dialysis Products and Services

• Peritoneal Dialysis Concentrates/Dialysates
• Peritoneal Dialysis Machines
• Peritoneal Dialysis Catheters
• Peritoneal Dialysis Transfer Sets
• Other products

Peritoneal Dialysis Modality

• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Ambulatory Peritoneal Dialysis (APD)

Disease Indication

• Acute Kidney Infections
• End-Stage Renal Disease
• Septic Shock
• Multi-Organ Failure
• Others

Usage

• In-Center Dialysis
• Hospital Dialysis
• Independent Dialysis
• Home Dialysis
• Peritoneal Dialysis
• Home Hemodialysis (HHD)

End User

• Hospitals
• Dialysis Centers
• Home Care Settings

Europe Hemodialysis and Peritoneal Dialysis Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, hemodialysis products, dialyzers material type, flux type, hemodialysis modality, hemodialysis water treatment systems, peritoneal dialysis products and services, peritoneal dialysis modality, disease indication, usage and end user as referenced above.

The countries covered in the market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and rest of Europe in Europe.

Germany is expected to dominate the Europe hemodialysis and peritoneal dialysis market due to its robust healthcare facilities, the significant presence of key market players, advanced healthcare infrastructure, and a substantial population afflicted with bone diseases and disorders, ensuring sustained market leadership.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

경쟁 환경 및 유럽 혈액 투석 및 복막 투석 시장 점유율 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• DaVita Inc. (미국)
• 백스터(미국)
• B. Braun SE(독일)
• 디아베룸 AB(스웨덴)
• Nipro Europe Group 회사(일본)
• NxStage Medical, Inc. (미국)
• 주식회사 닛키소(일본)
• Evoqua Water Technologies LLC. (미국)
• Asahi Kasei Medical Co., Ltd.(일본)
• Rockwell Medical, Inc. (미국)
• 메드트로닉(아일랜드)
• diallifegroup(이탈리아)
• JMS 주식회사(일본)
• 애틀랜틱 바이오메디컬(미국)
• 3M(미국)
• 올메드 메디컬 케어 홀딩스 리미티드(중국)
• 이소퓨어 주식회사(대만)
• BD(미국)

SKU-18491